The present study tested the feasibility of delivering miR-146a/-181b by affinity targeting to E-selectin and its effectiveness for the reduction of endothelial inflammation and atherosclerosis in apolipoprotein E-deficient (ApoE−/−) mice. Here, APOE is linked to atherosclerosis.